OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A homodimeric IL-15 superagonist F4RLI with easy preparation, improved half-life, and potent antitumor activities
Liangyin Lv, Hui Wang, Wenqiang Shi, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 21, pp. 7039-7050
Closed Access | Times Cited: 7
Liangyin Lv, Hui Wang, Wenqiang Shi, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 21, pp. 7039-7050
Closed Access | Times Cited: 7
Showing 7 citing articles:
Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer
Feifei Li, Sheng Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Feifei Li, Sheng Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside
Sogand Vahidi, Arefeh Zabeti Touchaei, Ali Akbar Samadani
International Immunopharmacology (2024) Vol. 133, pp. 112156-112156
Closed Access | Times Cited: 7
Sogand Vahidi, Arefeh Zabeti Touchaei, Ali Akbar Samadani
International Immunopharmacology (2024) Vol. 133, pp. 112156-112156
Closed Access | Times Cited: 7
Cancer immunotherapy focusing on the role of interleukins: A comprehensive and updated study
Mahmoud Samadi, Amin Kamrani, Hadi Nasiri, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154732-154732
Closed Access | Times Cited: 14
Mahmoud Samadi, Amin Kamrani, Hadi Nasiri, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154732-154732
Closed Access | Times Cited: 14
Cancer Immunotherapy
Javad Arabpour, Fatemeh Davodabadi, Manisha Nigam
(2025), pp. 49-113
Closed Access
Javad Arabpour, Fatemeh Davodabadi, Manisha Nigam
(2025), pp. 49-113
Closed Access
Mitotic MTH1 inhibitor TH1579 induces PD-L1 expression and inflammatory response through the cGAS-STING pathway
Jianyu Shen, Emilio Guillén Mancina, Shenyu Chen, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Jianyu Shen, Emilio Guillén Mancina, Shenyu Chen, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Oxidation and reduction analysis of therapeutic recombinant human interleukin-15 by HPLC and LC-MS
Yang Wang, Huanhuan Chen, Meiqi Zhao, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 10, pp. 3217-3227
Closed Access | Times Cited: 1
Yang Wang, Huanhuan Chen, Meiqi Zhao, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 10, pp. 3217-3227
Closed Access | Times Cited: 1
Mitotic MTH1 inhibitor TH1579 induces PD-L1 expression and inflammatory response through the cGAS-STING pathway
Thomas Helleday, Jianyu Shen, Emilio Guillén Mancina, et al.
Research Square (Research Square) (2023)
Open Access
Thomas Helleday, Jianyu Shen, Emilio Guillén Mancina, et al.
Research Square (Research Square) (2023)
Open Access
